Immunohistochemistry (HC) was invented in the 1940s and has developed to be a valuable tool for the identification of abnormal cells and cancerous tissues by using specific molecular markers. Additionally, IHC represents a excellent tool to analyze the distribution and localization of biomarkers and differentially expressed proteins in context of the specific biological tissue. Our tissue- & tumor-specific antibodies (see table) are well-established, highly published and robust tools in health care and pathology. To serve today´s urgent customer need for high quality and reliablility, all IHC antibodies have been externally validated and tested for optimal performance in relevant tissue and respective application.
The monoclonal antibody clones against keratin 20 (IT-Ks20.8),p53 (Bp53.11),vimentin (Vim3B4) and EP-CAM (HEA125) are only a few examples for approved clones that have been well trusted in the area of pathology for many years.